Anti-LSMD1/ NAA38/ MAK31 functional antibody

Anti-LSMD1/ NAA38/ MAK31 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NAA38/NAA38 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1630-Ab-1/ GM-Tg-hg-SE1630-Ab-2Anti-Human NAA38 monoclonal antibodyHuman
GM-Tg-rg-SE1630-Ab-1/ GM-Tg-rg-SE1630-Ab-2Anti-Rat NAA38 monoclonal antibodyRat
GM-Tg-mg-SE1630-Ab-1/ GM-Tg-mg-SE1630-Ab-2Anti-Mouse NAA38 monoclonal antibodyMouse
GM-Tg-cynog-SE1630-Ab-1/ GM-Tg-cynog-SE1630-Ab-2Anti-Cynomolgus/ Rhesus macaque NAA38 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1630-Ab-1/ GM-Tg-felg-SE1630-Ab-2Anti-Feline NAA38 monoclonal antibodyFeline
GM-Tg-cang-SE1630-Ab-1/ GM-Tg-cang-SE1630-Ab-2Anti-Canine NAA38 monoclonal antibodyCanine
GM-Tg-bovg-SE1630-Ab-1/ GM-Tg-bovg-SE1630-Ab-2Anti-Bovine NAA38 monoclonal antibodyBovine
GM-Tg-equg-SE1630-Ab-1/ GM-Tg-equg-SE1630-Ab-2Anti-Equine NAA38 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1630-Ab-1/ GM-Tg-hg-SE1630-Ab-2; GM-Tg-rg-SE1630-Ab-1/ GM-Tg-rg-SE1630-Ab-2;
GM-Tg-mg-SE1630-Ab-1/ GM-Tg-mg-SE1630-Ab-2; GM-Tg-cynog-SE1630-Ab-1/ GM-Tg-cynog-SE1630-Ab-2;
GM-Tg-felg-SE1630-Ab-1/ GM-Tg-felg-SE1630-Ab-2; GM-Tg-cang-SE1630-Ab-1/ GM-Tg-cang-SE1630-Ab-2;
GM-Tg-bovg-SE1630-Ab-1/ GM-Tg-bovg-SE1630-Ab-2; GM-Tg-equg-SE1630-Ab-1/ GM-Tg-equg-SE1630-Ab-2
Products NameAnti-NAA38 monoclonal antibody
Formatmab
Target NameNAA38
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NAA38 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1630-Ag-1Recombinant multi-species LSMD1/ NAA38/ MAK31 protein
    ORF Viral VectorvGMLP000024human LSMD1 Lentivirus particle
    ORF Viral VectorpGMLP000024human LSMD1 Lentivirus plasmid


    Target information

    Target IDGM-SE1630
    Target NameNAA38
    Gene ID84316,78304,287429,716462,479488,101100516,538931,100062142
    Gene Symbol and Synonyms1500034E06Rik,LSMD1,MAK31,NAA38,PFAAP2,RGD1559617
    Uniprot AccessionQ9BRA0
    Uniprot Entry NameLSMD1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183011
    Target ClassificationN/A

    The target: NAA38, gene name: NAA38, also named as LSMD1, MAK31, PFAAP2. Involved in negative regulation of apoptotic process. Located in cytoplasm and nucleoplasm. Part of NatC complex. Colocalizes with polysome. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.